Summit Therapeutics Inc.
Equity & Debt
| Period | Long Term Debt | Share Holder Equity | Cash on Hand |
|---|---|---|---|
| Jan 2018 | — | $-3.6M | $28.5M |
| Dec 2018 | — | $32.2M | $12.1M |
| Jan 2019 | — | $57.6M | $35.2M |
| Jun 2019 | — | $43.6M | — |
| Sep 2019 | — | $36.2M | $21.6M |
| Dec 2019 | — | $78.9M | $63.8M |
| Mar 2020 | — | $68.4M | $54.9M |
| Jun 2020 | — | $53.6M | $36.4M |
| Sep 2020 | — | $38.5M | $21.3M |
| Dec 2020 | — | $79.5M | $66.4M |
| Mar 2021 | — | $64.4M | $102.2M |
| Jun 2021 | — | $119.4M | $103.4M |
| Sep 2021 | — | $102.3M | $80.2M |
| Dec 2021 | — | $83.3M | $71.8M |
| Mar 2022 | — | $64.4M | $77.5M |
| Jun 2022 | — | $51.3M | $57.3M |
| Sep 2022 | — | $133.2M | $122.0M |
| Dec 2022 | — | $126.7M | $348.6M |
| Mar 2023 | — | $133.5M | $71.0M |
| Jun 2023 | — | $119.6M | $42.1M |
| Sep 2023 | — | $99.4M | $23.8M |
| Dec 2023 | — | $77.7M | $71.4M |
| Mar 2024 | — | $44.2M | $61.3M |
| Jun 2024 | — | $195.1M | $28.4M |
| Sep 2024 | — | $437.9M | $93.8M |
| Dec 2024 | — | $388.7M | $104.9M |
| Mar 2025 | — | $344.3M | $211.5M |
| Jun 2025 | — | $259.4M | $297.9M |
| Sep 2025 | — | $192.3M | $238.6M |
| Dec 2025 | — | $658.9M | $225.3M |
| Mar 2026 | — | $545.9M | $106.5M |
| Jun 2026 | — | $630.0M | $419.4M |
| Sep 2026 | — | $564.7M | $150.8M |